543904:BOM
Mankind Pharma Ltd
₹2,337.90
arrow_downward
-0.70%(-16.50) 1D
Jun 5, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 543904...
Open
₹2,351.35
High
₹2,369.00
Low
₹2,330.90
Mkt. cap
963.32B
Avg. vol.
96.72K
Volume
15.34K
Dividend
0.04%
Quarterly dividend
₹0.25
Ex-dividend date
Aug 8, 2025
P/E ratio
50.52
52-wk high
₹2,726.75
52-wk low
₹1,909.90
EPS
₹46.28
No. of employees
20K
Open
₹2,351.35
High
₹2,369.00
Low
₹2,330.90
Mkt. cap
963.32B
Avg. vol.
96.72K
Volume
15.34K
Dividend
0.04%
Quarterly dividend
₹0.25
Ex-dividend date
Aug 8, 2025
P/E ratio
50.52
52-wk high
₹2,726.75
52-wk low
₹1,909.90
EPS
₹46.28
No. of employees
20K
News stories
From sources across the web
The Economic Times
·
2 days ago
Mankind Pharma - Ipca Laboratories among 5 stocks showing bullish RSI upswing
MarketSmith India
·
2 days ago
STOCKS IN ACTION: Canara Bank, NHPC, Mankind Pharma, TCS and others
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees19.6K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com
AI content may include mistakes. Learn more